Bluewater Bio

23 articles about "Bluewater Bio"

‹‹ previous 1 2 3 next ››

Bluewater Bio enters a new phase of growth Vol 13, Issue 1 (January 2012)

The wastewater technology provider has turned profitable for the first time. It is weighing up a number of financing options to fund its aggressive roll-up strategy.

Liberating capital where it’s needed most Vol 13, Issue 1 (January 2012)

A group of ex-GE Water executives have carved out a niche providing capital for small value-from-waste projects. How long before other funds catch on to the idea?

NON-IPOS Vol 13, Issue 1 (January 2012)

Middle East contractor and developer Metito has said it is now unlikely to pursue an IPO in 2012, citing market instability.

AMERICA WATER IN BRIEF Vol 12, Issue 11 (November 2011)

* Liberation Capital, the private equity fund set up by ex-GE Water boss Jeff Garwood, is looking to raise a second round of capital in December, just four months after completing its first $60 million funding round.

Bluewater’s American odyssey Vol 12, Issue 11 (November 2011)

A new licensing agreement will see Bluewater Bio’s proprietary technology rolled out across the US. Its new partner stopped short of an equity stake.

INVESTABLE Vol 12, Issue 11 (November 2011)

Liberation Capital, the venture fund headed by GE veterans Jeff Garwood, Fred Schmuck and Earl Jones, has invested $8 million in UK-based wastewater treatment specialist Bluewater Bio.

Bluewater Bio enters desal market Vol 12, Issue 10 (October 2011)

The latest acquisition by the wastewater technology specialist will enable it to pursue opportunities in water reuse and desalination pre-treatment.

$20m revamp for old Tubli Vol 12, Issue 6 (June 2011)

Bahrain’s biggest WWTP is overused and sorely in need of an overhaul.

EUROPE WATER NEWS IN BRIEF Vol 11, Issue 10 (October 2010)

* The IPO of HaloSource on London’s Alternative Investment Market raised £50 million, including £31.5 million of new money, valuing the company’s equity at £100 million ($158 million).